The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:
ADVERTISEMENT

Opinion

View All

Shakespeare's Stratford-upon-Avon to 'decolonise' over concerns his success 'benefits the ideology of white European supremacy'

The trust, which manages historical buildings in Shakespeare’s hometown of Stratford-upon-Avon, says ...

ADHD diagnoses, prescriptions increase 10x amid Covid: NHS

Women in their late 20s and early 30s are now receiving ADHD prescriptions at ten times the rate seen...

Cardinal Zen: Chinese Communists Renew Crackdown on Chinese Catholics

As he continues his travels, the most important message Zen has for his audiences is: Stay informed a...

PM Keir Starmer says Putin's ceasefire response 'not good enough' as EU countries seek to pressure Russia

His remarks came after hosting a virtual summit aimed at rallying support for Ukraine and pressuring ...